NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes

Pharmacological Research

Volumn 63, Issue 5, 2011, Pages 405-413

  Surapureddi, Sailesh ^a   Rana, Ritu ^a   Goldstein, Joyce A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Co activators; CYP2C9; HNF4 ; NCOA6; PXR; Synergistic transactivation

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 4ALPHA; NUCLEAR RECEPTOR COACTIVATOR; NUCLEAR RECEPTOR COACTIVATOR 6; PREGNANE X RECEPTOR; RIFAMPICIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CYP2C9 GENE; CYP3A4 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

ARYL HYDROCARBON HYDROXYLASES; CHROMATIN IMMUNOPRECIPITATION; CYTOCHROME P-450 CYP3A; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN INTERACTION MAPPING; RECEPTORS, STEROID; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 79955468688     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.01.013     Document Type: Article

References (48)

1. D.R. Nelson, L. Koymans, T. Kamataki, J.J. Stegeman, R. Feyereisen, and D.J. Waxman P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 6 1996 1 42 (Pubitemid 26096749)
2. J.A. Goldstein, and S.M. de Morais Biochemistry and molecular biology of the human CYP2C subfamily Pharmacogenetics 4 1994 285 299
3. J.A. Goldstein Clinical relevance of genetic polymorphisms in the human CYP2C subfamily Br J Clin Pharmacol 52 2001 349 355 (Pubitemid 32939439)
4. T.K. Chang, L. Yu, J.A. Goldstein, and D.J. Waxman Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-km catalysts of cyclophosphamide and ifosfamide activation Pharmacogenetics 7 1997 211 221 (Pubitemid 27290635)
5. S. Gerbal-Chaloin, J.M. Pascussi, L. Pichard-Garcia, M. Daujat, F. Waechter, and J.M. Fabre Induction of CYP2C genes in human hepatocytes in primary culture Drug Metab Dispos 29 2001 242 251 (Pubitemid 32179522)
6. J. Raucy, L. Warfe, M.F. Yueh, and S.W. Allen A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system J Pharmacol Exp Ther 303 2002 412 423
7. A. Madan, R.A. Graham, K.M. Carroll, D.R. Mudra, L.A. Burton, and L.A. Krueger Effects of prototypical microsomal enzyme inducers on cytochrome p450 expression in cultured human hepatocytes Drug Metab Dispos 31 2003 421 431 (Pubitemid 36378519)
8. B.J. Komoroski, S. Zhang, H. Cai, J.M. Hutzler, R. Frye, and T.S. Tracy Induction and inhibition of cytochromes p450 by the St. John's Wort constituent hyperforin in human hepatocyte cultures Drug Metab Dispos 32 2004 512 518 (Pubitemid 38535029)
9. W. Zilly, D.D. Breimer, and E. Richter Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance Eur J Clin Pharmacol 9 1975 219 227
10. L. Kay, J.P. Kampmann, T.L. Svendsen, B. Vergman, J.E. Hansen, and L. Skovsted Influence of rifampicin and isoniazid on the kinetics of phenytoin Br J Clin Pharmacol 20 1985 323 326 (Pubitemid 16236886)
11. K.M. Williamson, J.H. Patterson, R.H. McQueen, K.F. Adams Jr., and J.A. Pieper Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers Clin Pharmacol Ther 63 1998 316 323 (Pubitemid 28182229)
12. L. Henderson, Q.Y. Yue, C. Bergquist, B. Gerden, and P. Arlett St. John's Wort (hypericum perforatum): drug interactions and clinical outcomes Br J Clin Pharmacol 54 2002 349 356 (Pubitemid 35334946)
13. S.S. Ferguson, E.L. LeCluyse, M. Negishi, and J.A. Goldstein Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site Mol Pharmacol 62 2002 737 746 (Pubitemid 36329394)
14. S. Gerbal-Chaloin, M. Daujat, J.M. Pascussi, L. Pichard-Garcia, M.J. Vilarem, and P. Maurel Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor J Biol Chem 277 2002 209 217 (Pubitemid 34952047)
15. Y. Chen, S.S. Ferguson, M. Negishi, and J.A. Goldstein Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor J Pharmacol Exp Ther 308 2004 495 501 (Pubitemid 38134210)
16. H.G. Xie, R.B. Kim, A.J. Wood, and C.M. Stein Molecular basis of ethnic differences in drug disposition and response Annu Rev Pharmacol Toxicol 41 2001 815 850 (Pubitemid 32385908)
17. S.A. Kliewer, and T.M. Willson Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor J Lipid Res 43 2002 359 364 (Pubitemid 34252265)
18. T. Sueyoshi, T. Kawamoto, I. Zelko, P. Honkakoski, and M. Negishi The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene J Biol Chem 274 1999 6043 6046 (Pubitemid 29111006)
19. I. Tzameli, P. Pissios, E.G. Schuetz, and D.D. Moore The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR Mol Cell Biol 20 2000 2951 2958 (Pubitemid 30215008)
20. L.B. Moore, J.M. Maglich, D.D. McKee, B. Wisely, T.M. Willson, and S.A. Kliewer Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors Mol Endocrinol 16 2002 977 986 (Pubitemid 34478535)
21. L.B. Moore, D.J. Parks, S.A. Jones, R.K. Bledsoe, T.G. Consler, and J.B. Stimmel Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands J Biol Chem 275 2000 15122 15127 (Pubitemid 30337234)
22. Y.E. Timsit, and M. Negishi CAR and PXR: the xenobiotic-sensing receptors Steroids 72 2007 231 246 (Pubitemid 46273513)
23. W. Xie, J.L. Barwick, C.M. Simon, A.M. Pierce, S. Safe, and B. Blumberg Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR Genes Dev 14 2000 3014 3023
24. W. Xie, A. Radominska-Pandya, Y. Shi, C.M. Simon, M.C. Nelson, and E.S. Ong An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids Proc Natl Acad Sci U S A 98 2001 3375 3380 (Pubitemid 32220853)
25. B. Goodwin, L.B. Moore, C.M. Stoltz, D.D. McKee, and S.A. Kliewer Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor Mol Pharmacol 60 2001 427 431 (Pubitemid 32781548)
26. D. Smirlis, R. Muangmoonchai, M. Edwards, I.R. Phillips, and E.A. Shephard Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics J Biol Chem 276 2001 12822 12826
27. P. Honkakoski, R. Moore, K.A. Washburn, and M. Negishi Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene Mol Pharmacol 53 1998 597 601 (Pubitemid 28196480)
28. T. Kawamoto, T. Sueyoshi, I. Zelko, R. Moore, K. Washburn, and M. Negishi Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene Mol Cell Biol 19 1999 6318 6322 (Pubitemid 29399336)
29. R.X. Xu, M.H. Lambert, B.B. Wisely, E.N. Warren, E.E. Weinert, and G.M. Waitt A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer Mol Cell 16 2004 919 928 (Pubitemid 40018402)
30. K. Suino, L. Peng, R. Reynolds, Y. Li, J.Y. Cha, and J.J. Repa The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization Mol Cell 16 2004 893 905 (Pubitemid 40018400)
31. D.D. Moore CAR: three new models for a problem child Cell Metab 1 2005 6 8 (Pubitemid 43960590)
32. G.C. Ibeanu, and J.A. Goldstein Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions Biochemistry 34 1995 8028 8036
33. R. Jover, R. Bort, M.J. Gomez-Lechon, and J.V. Castell Cytochrome p450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting Hepatology 33 2001 668 675 (Pubitemid 32185230)
34. Y. Chen, G. Kissling, M. Negishi, and J.A. Goldstein The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter J Pharmacol Exp Ther 314 2005 1125 1133 (Pubitemid 41205977)
35. F.M. Sladek, and J.E. Darnell Mechanisms of liver-specific gene expression Curr Opin Genet Dev 2 1992 256 259
36. C. Hu, and D.H. Perlmutter Regulation of alpha1-antitrypsin gene expression in human intestinal epithelial cell line CACO-2 by HNF-1alpha and HNF-4 Am J Physiol 276 1999 G1181 1194
37. S. Surapureddi, R. Rana, J.K. Reddy, and J.A. Goldstein Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome p-450 2c9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha Mol Pharmacol 74 2008 913 923
38. C. Qi, S. Surapureddi, Y.J. Zhu, S. Yu, P. Kashireddy, and M.S. Rao Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis J Biol Chem 278 2003 25281 25284 (Pubitemid 36835274)
39. Y. Zhu, L. Kan, C. Qi, Y.S. Kanwar, A.V. Yeldandi, and M.S. Rao Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR J Biol Chem 275 2000 13510 13516 (Pubitemid 30257416)
40. Q. Li, M.J. Chu, and J. Xu Tissue- and nuclear receptor-specific function of the c-terminal LXXLL motif of coactivator NCOA6/AIB3 in mice Mol Cell Biol 2007
41. R.G. Tirona, W. Lee, B.F. Leake, L.B. Lan, C.B. Cline, and V. Lamba The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4 Nat Med 9 2003 220 224 (Pubitemid 36227725)
42. I. Echchgadda, C.S. Song, T. Oh, M. Ahmed, I.J. De La Cruz, and B. Chatterjee The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4{alpha} in the regulation of human steroid-/bile acid-sulfotransferase Mol Endocrinol 21 2007 2099 2111 (Pubitemid 47347375)
43. X. Ding, K. Lichti, I. Kim, F.J. Gonzalez, and J.L. Staudinger Regulation of constitutive androstane receptor and its target genes by fasting, camp, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha J Biol Chem 281 2006 26540 26551 (Pubitemid 44401863)
44. C. Chung, J.A. Doll, V.M. Stellmach, J. Gonzales, S. Surapureddi, and M. Cornwell Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha Adv Exp Med Biol 617 2008 591 597
45. K. Inoue, and M. Negishi Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome p450 2b6 gene J Biol Chem 283 2008 10425 10432
46. K. Inoue, and M. Negishi Early growth response 1 loops the CYP2B6 promoter for synergistic activation by the distal and proximal nuclear receptors CAR and HNF4alpha FEBS Lett 583 2009 2126 2130
47. H.L. Fang, S.C. Strom, E. Ellis, Z. Duanmu, J. Fu, and Z. Duniec-Dmuchowski Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4{alpha} and pregnane X receptor J Pharmacol Exp Ther 2007
48. T. Li, and J.Y. Chiang Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression Drug Metab Dispos 34 2006 756 764